Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Type-1 angiotensin II receptor antagonists discovered at MFC

June 5, 2020

iPSC microtissue gives clues to heart disease

June 4, 2020

Tenax Therapeutics reports positive phase II results for levosimendan in PH-HFpEF

June 3, 2020

FDA approves Brilinta to reduce first heart attack in patients with coronary artery disease

June 2, 2020

MyoKardia synthesizes new cardiac myosin inhibitors

May 21, 2020

Lyfaquin approved in India for hypovolemic shock

May 15, 2020

Liver-specific pre-eclampsia treatment is maternal-specific

May 15, 2020

TransThera studies TT-00920 for heart failure in first-in-human study

May 13, 2020

Enabling P-TEFb-dependent transcription of Myc in heart restores cardiomyocyte proliferation

May 13, 2020

Integrated herpesvirus 6 is pre-eclampsia risk factor

May 13, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...